Vacancy expired!
Boehringer Ingelheim is currently seeking a creative and innovative Post-Doctoral Fellow to join the Myeloid and Dendritic Cell Biology group within the Department of Cancer Immunology and Immune Modulation, to investigate cellular and molecular interactions in the tumor microenvironment and in lymphoid organs that affect anti-tumor immunity.
This 2-year post (with potential for 1-2 year extension) is anticipated to provide new insights into tumor-stromal-immune crosstalk for high-impact publications.
A PhD in Biosciences with a strong background in cancer immunology, tumor stromal biology orangiogenesis is preferred, together with relevant cell culture and assay experience.
As an employee of Boehringer Ingelheim, you will actively contribute to the discovery, development and delivery of our products to our patients and customers.
Our global presence provides opportunity for all employees to collaborate internationally, offering visibility and opportunity to directly contribute to the companies' success.
We realize that our strength and competitive advantage lie with our people. We support our employees in a number of ways to foster a healthy working environment, meaningful work, diversity and inclusion, mobility, networking and work-life balance.
Our competitive compensation and benefit programs reflect Boehringer Ingelheim's high regard for our employees.
Duties and Responsibilities :
As a Post-Doctoral Fellow you will benefit from a fully resourced and fully funded research environment with access to state-of-the-art tools, technologies and equipment.
You will assume full responsibility for a research project, working closely with a senior research technician and an experienced mentor, and will leverage collaboration opportunities within BI across departments and across sites as well as with academic collaborators.
Embedded in the BI Research organization, you will have regular access to other BI scientists beyond your immediate lab to discuss your science and define the best possible approach at each stage of your project.
You will become part of BI’s international, multi-site Postdoc community, and you will benefit from vibrant scientific discussions with scientists and peers locally as well as globally via using state-of-the-art telecommunication technology and via regular Postdoc retreats.
You will receive sponsorship for attendance of relevant scientific conferences.
You will be expected to publish your scientific results in peer-reviewed journals and present your data at international immunology conferences.
You will be supported by your mentor to define the optimal publication strategy for conference abstracts and actual manuscripts.
Although Postdoc projects are basic science-focused you will gain valuable insights in the drug discovery process via interactions with scientists inside and outside of Boehringer Ingelheim’s Cancer Immunology and Immune Modulation department
Requirements :
PhD in Biosciences with a strong background in tumor stromal biology, angiogenesis or cancer immunology required.
Prior research experience of relevant in vitro experimental techniques / approaches including cell culture of relevant primary cells (fibroblasts, immune cells etc.
and flow cytometry is preferred.
Experience with in vivo mouse models is required.
Ability to optimize and develop assays / techniques, as well as leverage new technology opportunities, to address scientific questions effectively
Evidence of scientific rigor and excellence in stromal biology / cancer immunology as documented by relevant peer-reviewed publications
Critical and creative thinking, self-motivated to innovate, and organized
Excellent communication, networking and presentation skills, as well as excellent data analysis and data management skills
Eligibility Requirements :
Must be legally authorized to work in the United States without restriction.
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older
Who We Are :
At Boehringer Ingelheim we create value through innovation with one clear goal : to improve the lives of patients. We develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals.
As a family owned company we focus on long term performance. We are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture.
Learning and development for all employees is key because your growth is our growth.
